Espinosa, E., Valitutti, S., Laroche, M., Laurent, C., Apoil, P. A., Hermine, O., . . . Bulai Livideanu, C. (2018). Hydroxychloroquine as a novel therapeutic approach in mast cell activation diseases. Clinical immunology (Orlando, Fla.), 194, 75. https://doi.org/10.1016/j.clim.2018.07.004
Style de citation ChicagoEspinosa, Eric, Salvatore Valitutti, Michel Laroche, Camille Laurent, Pol André Apoil, Olivier Hermine, Michel Lavit, Carle Paul, et Cristina Bulai Livideanu. "Hydroxychloroquine as a Novel Therapeutic Approach in Mast Cell Activation Diseases." Clinical Immunology (Orlando, Fla.) 194 (2018): 75. https://dx.doi.org/10.1016/j.clim.2018.07.004.
Style de citation MLAEspinosa, Eric, et al. "Hydroxychloroquine as a Novel Therapeutic Approach in Mast Cell Activation Diseases." Clinical Immunology (Orlando, Fla.), vol. 194, 2018, p. 75.